Andrés Morales la Madrid
Investigador colaborador
Research group
Medicine Degree (2002) by the Universidad Peruana Cayetano Heredia (Peru). Specialty in Pediatrics (2007) from Vall Hebron Hospital (Spain). Sub Specialty in Oncology, Hematology and Stem Cell Transplantation in Pediatrics (2012) from the University of Chicago (USA). Sub Specialty in Pediatric Neuro Oncology (2013) from Harvard University (2013). Master in Hospital Management and Health Resources (2018) from the University of Barcelona (Spain).
In 2018, he was appointed Clinical Director of the Oncology Area of the SJD Barcelona Children Hospital, Spain.
He leads a clinical research project in immunotherapy for the diffuse intrinsic pontine glioma (DIPG).
Professional network profiles
Related websites
SJD Barcelona Children Hospital Last Publications
- Marina Caballero Bellón, Santa-María López V, Marti-Sanchez L, Martorell-Sampol L, Salinas D, Hinojosa J, Becerra MV, Pavon-Mengual M, Morales-La Madrid A, Cruz-Martínez O, Muchart-Lopez J and Salvador-Hernandez H Very early-onset symptomatic CNS haemangioblastoma in Von Hippel-Lindau disease. JOURNAL OF MEDICAL GENETICS . 62(6): 409-412.
- Erker C, Mynarek M, Simbozel M, Craig BT, Harrod VL, Cappellano AM, Cohen KJ, Santa-María López V, Morales-La Madrid A, Cacciotti C, Baroni L, Salloum R, Margol AS, Michaiel G, Aguilera D, Mazewski CM, Kline CN, Finlay JL, Abdelbaki MS, Murray JC, Dorris K, Crooks B, Ginn KF, Amayiri N, Tippelt S, Fleischhack G, Tonn S, Gerber NU, Lassaletta A, Hansford JR, Khan S, Gilheeney SW, Hoffman LM, Zapotocky M, Larouche V, Shah S, Ramaswamy V, Gajjar A, Perreault S, Mueller S, Hukin J, Cheng S, Wang ZJ, Matheson K, Bailey S, Bouffet E, Clifford SC, Robinson G, Dufour C, Rutkowski S and Lafay-Cousin L Salvage therapies for first relapse of SHH medulloblastoma in early childhood Neuro-Oncology . : .
- Ruiz J, Robles JM, Sánchez LM, Khan A, Lu AD, Marjerrison S, Morales-La Madrid A and Aristizabal P Achieving Language Justice in Pediatric Hematology-Oncology: A Multinational Perspective for Language-Concordant Equitable Patient- and Family-Centered Care and Research Inclusion PEDIATRIC BLOOD & CANCER . 72(4): .
Projects
- Project name:
- ADVANCED THERAPIES (RICORS-TERAV)
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- RD24/0014/0006
- Starting - finishing date:
- 2025 - 2027
- Project name:
- GLIOMATCH_The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics
- Leader
- Andrés Morales La Madrid
- Funding entities:
- Lavarino, Cinzia Emilia, European Commission, Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- 101136670
- Starting - finishing date:
- 2024 - 2028
- Project name:
- Ensayo clínico de seguridad y factibilidad de inmunoterapia celular: Células dendríticas autólogas pulsadas con un lisado de líneas tumorales alogénicas, asociadas con CART anti-IL13Ra2 en pacientes con tumor difuso intrínseco de tronco (DIPG) (fase Ib)
- Leader
- Andrés Morales La Madrid
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI23/00063
- Starting - finishing date:
- 2024 - 2027
News
-
The Institut de Recerca Sant Joan de Déu drives the first in-person meeting of the cancer Survivorship Network of Expertise of the JANE2 project
On May 9th, the Institut de Recerca Sant Joan de Déu (IRSJD) brought together the leaders of the Survivorship Network of Expertise, a network framed within the Joint Action on Network of Expertise (JANE2) project, one of the pillars of the European Beating Cancer Plan. During the meeting, key challenges and activities to advance care for cancer survivors in Europe were addressed, and a "working definition" was proposed to help establish an integrative care model for survivors.